Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-56,968
Closed -$837K 1815
2025
Q3
$837K Buy
+56,968
New +$581K 0.05% 380
2023
Q3
Sell
-10,073
Closed -$191K 1467
2023
Q2
$191K Sell
10,073
-46,545
-82% -$817K 0.01% 835
2023
Q1
$862K Buy
+56,618
New +$738K 0.09% 218
2022
Q4
Sell
-32,883
Closed -$190K 1769
2022
Q3
$190K Buy
32,883
+12,661
+63% +$55.6K 0.02% 891
2022
Q2
$65K Buy
+20,222
New +$61K 0.01% 1052

Other funds holding ETNB

Virtu Financial's ETNB Position: Q4 2025 in Review

Virtu Financial sold out of 89bio (ETNB) in Q4 2025, closing a stake of 56,968 shares — an estimated $837K sold.

Virtu Financial first reported a position in ETNB in Q2 2022 and held it in 5 quarters. The position peaked at $862K in Q1 2023. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Virtu Financial reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Virtu Financial sold 56,968 89bio shares in Q4 2025, an estimated $837K.
  • Virtu Financial first reported a position in 89bio in Q2 2022 and held it in 5 quarters.
  • Virtu Financial's 89bio position peaked at $862K in Q1 2023.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.